32.48 USD
+0.01 (+0.03%)
32.48 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 54% to CBAY. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 33.15. This target is 2.06% above the current price.
CBAY was analyzed by 16 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about CBAY.
In the last month the buy percentage fell by 33 points. So the trust of analysts is decreasing.
CBAY was analyzed by 16 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-02-29 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-02-20 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-02-14 | LifeSci Capital | Downgrade | Outperform -> Market Perform |
| 2024-02-14 | UBS | Downgrade | Buy -> Neutral |
| 2024-02-14 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2024-02-13 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2024-02-13 | JonesTrading | Downgrade | Buy -> Hold |
| 2024-02-13 | BTIG | Downgrade | Buy -> Neutral |
| 2024-02-13 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2024-02-13 | Raymond James | Downgrade | Strong Buy -> Market Perform |
| 2024-02-13 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-02-12 | William Blair | Downgrade | Outperform -> Market Perform |
| 2023-12-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-08 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2023-11-08 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2023-11-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-07 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-11-06 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-09-26 | UBS | Maintains | Buy -> Buy |
| 2023-09-08 | BTIG | Maintains | Buy -> Buy |
| 2023-09-08 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-09-08 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2023-09-07 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2023-09-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-31 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-15 | JonesTrading | Maintains | Buy -> Buy |
| 2023-08-14 | UBS | Initiate | Buy |
| 2023-08-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-11 | Guggenheim | Initiate | Buy |
| 2023-08-11 | BTIG | Maintains | Buy -> Buy |
CYMABAY THERAPEUTICS INC / CBAY FAQ
What is the price target for CBAY stock?
16 analysts have analysed CBAY and the average price target is 33.15 USD. This implies a price increase of 2.06% is expected in the next year compared to the current price of 32.48.
What is the consensus rating for CYMABAY THERAPEUTICS INC (CBAY) stock?
The consensus rating for CYMABAY THERAPEUTICS INC (CBAY) is 53.75 / 100 . This indicates that analysts generally have a neutral outlook on the stock.